🔗 Share this article

While America undertakes historic adjustments to its vaccination schedules, one figure has emerged in a surprising turn: Høeg, a Danish American sports physician and public health researcher who first made her name by expressing skepticism about COVID-19 vaccines in the global health crisis and has concentrated on possible deaths after Covid vaccination in her short tenure at the US Food and Drug Administration (FDA).

Scheduled Overhauls to Pediatric Vaccine Schedule

Health officials planned to reveal sweeping revisions to the childhood vaccination calendar earlier this month, bringing the US with Denmark’s national calendar, sources say – a substantial departure that would put the US out of alignment with many the international standard with insufficient data for benefit. The announcement has been delayed until the next year.

Rather than Vinay Prasad, Tracy Beth Høeg is listed to speak at the meeting. She was newly appointed temporary leader of the FDA’s CDER, the fifth appointee to lead the office this year.

A New Direction at the Regulatory Body

Høeg's temporary position could signify a strengthened alliance between the pharmaceutical and biologics divisions as Høeg and Dr. Prasad solidify control at the regulatory agency – and it signals a increased emphasis upon rolling back previously authorized immunizations at the FDA.

Dr. Høeg has frequently advocated for ending specific childhood vaccine recommendations in the US to become more in line with Denmark's approach, a country with comprehensive healthcare and a citizenry about the population of the state of Wisconsin.

To date public appearances, she has continued to focus on immunizations – traditionally the responsibility of Prasad, director of the FDA’s CBER – as opposed to medication approval.

Doubts Over Qualifications

Høeg has no apparent experience in drug development, regulation or administrative roles, which has been customary for past leaders of the Center for Biologics Evaluation and Research. She has worked at the FDA as a top consultant to the FDA chief and the vaccine center since March.

“She appears not to have the requisite experience” for running the drug-regulation department, said a neurologist and psychiatrist. “She has not conducted a clinical trial. She is not versed in leading a major agency. She lacks background in pharmaceutical oversight.”

Past directors of CBER would “grasp regulatory frameworks and the underlying principles of pharmaceutical innovation”, said Janet Woodcock. “Clearly, she has not acquired the sort of resume that previous people who ran the center have had.”

CDER has an enormous range of responsibilities at the FDA, Woodcock stated.

“Many people just pays attention on the novel medication approvals, but the generic drug division approves a multitude of generic medications. There’s a biologic copycat branch, non-prescription drug unit and other areas, and every single one must be managed,” Woodcock noted. “The area you overlook, that is precisely what that I always told people is going to bite you.”

Additionally, a major management aspect to the position, which oversees more than 5,000 employees. “It is a huge administrative position, if you execute it properly,” the former official concluded.

Agency Reaction and Contentious Policies

When asked about inquiries about Høeg’s qualifications and whether this assignment represents increased cooperation among FDA leaders on vaccines, a representative said that the “concerns rely on inaccurate presumptions”.

“Her resume aligns with the duties of her position,” the spokesperson said, noting the months Dr. Høeg spent counseling the agency head on “drug safety and regulatory science, including computational safety modeling and shot safety tracking”.

As the temporary head, Høeg assumes responsibility for the commissioner’s controversial expedited review system, a contentious rapid medication authorization process that apparently troubled her preceding directors. “How are these medications being chosen for this fast-track system? Who takes the decisions?” Dr. Howard questioned. “There’s a lot of lack of transparency occurring at the agency right now.”

In general, he stated, “the agency looks to be trending towards more relaxed oversight of all drugs, aside from shots.”

Documented Past Work on Immunizations

Regarding vaccines, Høeg has a more documented, if problematic, history, critics said. She authored a study using unconfirmed crowd-sourced reports to determine the rate of myocarditis following Covid immunization. She advised the Florida surgeon general Joseph Ladapo, who reportedly have changed statistics to suggest COVID-19 vaccinations are more dangerous than they are.

Included in her “desired changes” for the new government encompassed changing regulations for new vaccines and discontinuing “optional” immunizations, she remarked after the election on a audio program. At the agency, Høeg has reportedly proposed barring young men from obtaining Covid vaccinations.

“She’s an all-around dogmatist who starts off with her conclusions and works backwards to retrofit the data in a highly disingenuous, dishonest manner,” Dr. Howard stated.

Consolidating Power and a “Push for Payback”

Dr. Høeg joined fellow dissenters, {like|